C4 Therapeutics (C4T) is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Feb 23, 2023
Feb 8, 2023
Jan 30, 2023
February 21, 2023 at 12:00 PM EST
February 15, 2023 at 3:00 PM EST
February 10, 2023 at 10:00 AM EST